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Antibiotic resistance is a prominent food safety concern. Antibiotics given to food 
animals may promote the development of antibiotic resistance within bacterial populations, 
which then poses a threat to both workers in food animal operations and consumers. A previous 
study was performed which sought to analyze the effects of ceftiofur and chlortetracycline on 
pan-susceptible and multidrug-resistant (MDR) strains of Salmonella in swine. The purpose of 
this study was to optimize protocols for quantitative PCR (qPCR) to detect and quantify 
antibiotic resistance genes, specifically qnrB19 and blaSHV-12, from swine fecal samples. These 
antibiotic resistance genes were chosen in order to uniquely identify the MDR Salmonella strains 
that were used to challenge the swine. The invA gene was also analyzed to determine the total 
number of Salmonella within the fecal samples, allowing for comparison between pan-
susceptible and MDR Salmonella quantities. The protocols created for qnrB19 and blaSHV-12 
were successfully optimized and are ready for use in sample analysis, but further work still 
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Antibiotics used in food animal operations have been shown to promote antibiotic 
resistance in bacterial strains, which later poses a food safety risk to human consumers and 
operation workers.[1] Antibiotics are used in swine operations to control, prevent, and treat 
disease. Antibiotics commonly used in the swine industry include ceftiofur,[2] chlortetracycline,[3] 
amoxicillin,[4] and enrofloxacin.[5] Antibiotics have been found to promote antibiotic resistance in 
swine, selecting for antimicrobial resistance (AMR) in bacterial strains and promoting their 
growth while eliminating susceptible strains.[6],[7] Use of these antibiotics have been positively 
correlated with increases in AMR genes such as blaCMY, aac(3)-VI, aadA, blaCTX-M, blaTEM, 
blaSHV. tetA, tetC, qepA, qnrB, qnrS, ermA, ermT, cfxA, cepA, cblA, hla, eta, etb.[8],[9],[10],[11],[12] 
By monitoring how these genes are selected for when exposed to antibiotics, we have the ability 
to more accurately predict what kind of food safety risk may be brought about by antibiotic use 
in swine operations. This allows operation workers and veterinarians to make more accurate 
judgement calls in any given situation where antibiotics may be necessitated; the potential harm 
to the operation can be weighed against the potential harm to the workers and consumers. One 
such method of observation is qPCR. 
Quantitative PCR (qPCR) is a form of gene detection that allows the user to observe the 
amplification in real time.[13] While traditional end-point PCR is effective for confirming 
whether or not a gene is present within a sample, qPCR allows for the user to quantify how much 
of the gene is present by seeing how it amplifies compared to standards with known 
quantities.[13] Additionally, it offers much greater discrimination between gene quantities than 
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can be found with end-point PCR, allowing for more precise measurements of gene quantity.[13] 
However, it is limited by factors such as the specificity of its reagents.[13] Primer sequences are 
used to amplify specific regions of the target genome, but if those sequences do not correspond 
to regions specific to that gene and instead correspond to gene sequences found in multiple 
genomes then results may be confounded by an inability to discriminate between products.[13] 
Despite this, it remains an efficient tool in the use gene amplification, and is of great use in the 
detection of microbial genetics.[13] 
1.2 Preliminary Swine Trials 
A previous project was performed within the lab wherein 32 swine were challenged 
orally with both pan-susceptible and multidrug-resistant (MDR) strains of Salmonella enterica 
serovar Derby (S. Derby) and intradermally with both pan-susceptible and MDR strains of 
Salmonella enterica serovar Senftenberg (S. Senftenberg). The swine were then treated with 
antibiotics after the bacteria were given time to colonize the swine. Fecal samples were collected 
on every day of the trial and lymph nodes were collected at the end of the trial following 
euthanasia. We hypothesize that the use of antibiotics will decrease the Salmonella population; 
however, the proportion of MDR resistant Salmonella will increase. 
The purpose of this study was to optimize protocols for qPCR analysis of the presence of 
the qnrB19 and blaSHV-12 genes within the fecal samples collected from this previous study to 
detect and quantify the MDR resistant Salmonella challenge strains. A qPCR protocol for the 
invA gene was also optimized to quantify the total amount of Salmonella in the fecal samples.[14] 
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2. MATERIALS AND METHODS 
2.1 Study Design 
In the initial trial, 32 swine were challenged orally with both pan-susceptible and 
multidrug-resistant (MDR) strains of Salmonella enterica serovar Derby (S. Derby) and 
intradermally with both pan-susceptible and MDR strains of Salmonella enterica serovar 
Senftenberg (S. Senftenberg) following a 2 week quarantine period. The S. Derby MDR strain 
uniquely displayed the antimicrobial resistance gene qnrB19 while the S. Senftenberg MDR 
strain uniquely displayed the antimicrobial resistance gene blaSHV-12 (Table 2.1). The animals 
were challenged on Day 1 and Day 3 of the study. Animals were then treated with either 
ceftiofur, chlortetracycline, both antibiotics, or neither antibiotic in order to determine the effects 
of these antibiotics on the presence of pan-susceptible and MDR strains of Salmonella within the 
feces and lymph nodes of the swine. Antibiotic treatments were initiated on Day 5, with ceftiofur 
being given as an intramuscular injection behind the ear at a dose of 2.27 mg/lb, and 
chlortetracycline being given as a top dressing in feed from Day 5 through Day 18 at a dose of 
400g/ton. Fecal samples were collected on every day of the trial until the swine were euthanized 




Table 2.1: Antimicrobial resistance phenotypes and genotypes determined by whole genome sequencing of the four 
Salmonella strains used in the swine challenge study 
 
2.2 DNA Extraction 
DNA extractions of positive control Salmonella isolates for qPCR were performed on the 
QIAcube (Qiagen; Hilden, Germany) utilizing the DNeasy Blood and Tissue Mini Kit (50) 
(Qiagen) plus QIAamp DNA Accessory Set A (Qiagen). Assessment of overall DNA quality was 
performed on the FLUOstar Omega microplate reader (BMG Labtech; Hopkinton, MA) and 
assessed for a 260/280 absorbance value between 1.8 and 2.0. A final DNA concentration for 
each sample was obtained using a Qubit 3 Fluorometer (Thermo Fisher Scientific; Houston, TX). 
The qPCR reactions were all performed using appropriate concentrations of Invitrogen UltraPure 
DNase/RNase Free Distilled Water (Thermo Fisher Scientific), Brilliant III Ultra-Fast SYBR 
Green QPCR Master Mix with Low ROX (Agilent Technologies; Santa Clara, CA) or Brilliant 
III Ultra-Fast Probe Master Mix with Low ROX (Agilent Technologies) (depending on whether 
the protocol calls for a fluorescent probe or not), and the appropriate primer set for each gene 
corresponding to the optimized protocol for each reaction (See below for further details for each 
Salmonella 







aac(6'), aac(6')-I, aac(6')-IIc, aadA, aph(3')-





Derby C79C1 MDR aadA, qnrB, sul1, tet(A) 
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primer set). Standard curve dilutions and qPCR reactions were prepared in the QIAgility 
(Qiagen) or prepared by hand. The final reaction was performed using the AriaMx Real-time 
PCR System (Agilent Technologies). Final data analyses were performed using the AriaMx 
software (Agilent Technologies). The standard curves were analyzed for R2, slope, and 
efficiency values. The accepted range values for these are -3.58 to -3.10, 90% to 110%, and 
>0.99 for slope, efficiency, and R2 respectively.[15] 
2.3 qnrB19 Primer Set 
The qnrB19 primer set was generated through the use of IDT’s PrimerQuest program. 
The gene[16] was copied in and the 2 Primers + Probe option was selected in order to generate a 
primer set with probe for increased specificity. 
The qnrB19 reactions were performed using 5-5.6 µL of water (Thermo Fisher 
Scientific), 10 µL of Brilliant III Ultra-Fast Probe Master Mix with Low ROX (Agilent 
Technologies), 0.5-2.5 µL of both the forward and reverse qnrB19 primer sets (Table 2.2) (IDT) 
(concentration 5µM), 0.4-1 µL of the qnrB19 probe (Table 2.2) (IDT) (concentration 1-5µM), 
and 2 µL of DNA template per reaction. Different concentrations and quantities of the primers 
were assessed to determine the optimal concentration. The reactions were performed in duplicate 
by hand with 4.0 µL of template and 36.0 µL of Master Mix which was then hand-mixed and 
separated into 20 µL reactions for analysis. 
Table 2.2: The qnrB19 forward and reverse primer and probe sequences 
qnrB19 Forward Primer Sequence 5´- CGA CGT TCA GTG GTT CAG AT -3´ 
qnrB19 Reverse Primer Sequence 5´- CCT AAC TCC GAA TTG GTC AGA T -3´ 
qnrB19 Probe Sequence 5’ - /56-FAM/AA TGT GTG A/ZEN/A GTT TGC TGC TCG CC/3IABkFQ/ -3´ 
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Reactions in the AriaMx (Agilent Technologies) were performed utilizing the 
Quantitative PCR – Fluorescence Probe program beginning with 3 minutes at 95°C to initiate the 
reaction, followed by 40 repeating cycles of 5 seconds at 95°C followed by 10 seconds at an 
annealing temperature ranging from 55°C to 70°C (different temperatures were tested) with 
measurements taken following each amplification cycle. Different annealing temperatures were 
assessed to determine the optimal temperature. 
2.4 blaSHV-12 Primer Set 
The primer sets were previously generated by a graduate student within the lab through 
use of IDT’s PrimerQuest program. 
The blaSHV-12 reactions were performed using 2-3 µL of water (Thermo Fisher Scientific), 
10 µL of Brilliant III Ultra-Fast SYBR Green QPCR Master Mix with Low ROX (Agilent 
Technologies), 2.5-3.0 µL of both the forward and reverse blaSHV-12 primer sets (Table 2.3) 
(IDT) (concentration 5µM), and 2 µL of DNA template per reaction. Different quantities of the 
primers were assessed to determine the optimal concentration. The reactions were performed in 
duplicate by hand with 4.0 µL of template and 36.0 µL of Master Mix which was then hand-
mixed and separated into 20 µL reactions for analysis. 
Table 2.3: The blaSHV-12 forward and reverse primer sequences 
blaSHV-12 Forward Primer Sequence 5´- ATA AGA CCG GAG CTA GCA AAC -3´ 
blaSHV-12 Reverse Primer Sequence 5´- GGC GTA TCC CGC AGA TAA AT -3´ 
 
Reactions in the AriaMx (Agilent Technologies) were performed utilizing the 
Quantitative PCR – DNA Binding Dye Including Standard Melt program beginning with 3 
minutes at 95°C to initiate the reaction, followed by 40 repeating cycles of 5 seconds at 95°C 
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followed by 10 seconds at temperatures ranging from 60°C to 65°C (different temperatures were 
tested) with measurements taken following each amplification cycle. Different annealing 
temperatures were assessed to determine the optimal temperature. Following the amplification 
cycles the reactions were returned to 95°C for 1 minute, cooled to 55°C for 30 seconds, and 
returned to 95°C for 30 more seconds in order to generate a melting curve. Data was collected 
along the temperature increase from 55°C to 95°C. The melting curve was analyzed to ensure 
that only a singular product was generated. If all generated products displayed the same melting 
curve, then it can be assumed that all generated products were of the same substance, if not 
concentration. 
2.5 invA Primer Set 
The invA reactions were performed using 4.6-5 µL of water (Thermo Fisher Scientific), 
10 µL of Brilliant III Ultra-Fast Probe Master Mix with Low ROX (Agilent Technologies), 1 µL 
of both the forward and reverse invA primer sets[8] (Table 2.4) (concentration 0.5µM), 0-0.4 µL 
of probe[8] (Table 2.4) (concentration 0.5µM), and 2 µL of DNA template per reaction. The 
reactions were performed in duplicate and at a 1.1X quantity to account for pipetting error within 
the QIAgility (Qiagen), resulting in final preparations consisting of 4.4 µL of template and 39.6 
µL of Master Mix which was then briefly hand-mixed and separated into 20 µL reactions by 




Table 2.4: The invA forward and reverse primer and probe sequences[17] 
invA_176_F Forward Primer Sequence 5´- CAA CGT TTC CTG CGG TAC TGT -3´ 
invA_291_R Reverse Primer Sequence 5´- CCC GAA CGT GGC GAT AAT T -3´ 
invA_FAM_208 Probe Sequence 5´- /56-FAM/CTC TTT CGT CTG GCA TTA TCG ATC AGT ACC A/3IAbRQSp/ -3´ 
 
Reactions in the AriaMx (Agilent Technologies) were performed utilizing the 
Quantitative PCR – Fluorescence Probe program beginning with 3 minutes at 95°C to initiate the 
reaction, followed by 40 repeating cycles of 5 seconds at 95°C followed by 10 seconds at 60°C 
with measurements taken following each amplification cycle. 
Two runs were performed using differing control template DNA in order to test if 
detected issues were resultant from the reagents used. A third test was run using the Quantitative 
PCR – DNA Binding Dye Including Standard Melt program beginning with 3 minutes at 95°C to 
initiate the reaction, followed by 40 repeating cycles of 5 seconds at 95°C followed by 10 
seconds at 60°C with measurements taken following each amplification cycle. Following the 
amplification cycles the reactions were returned to 95°C for 1 minute, cooled to 65°C for 30 





3.1 qnrB19 gene Protocol Optimization 
Multiple protocols were tested for the qnrB19 gene (Table 3.1), including protocols 
utilizing qnrB19 primers previously generated in the lab using IDT’s PrimerQuest system 
(unpublished). When no adjusting of annealing temperatures or primer concentration succeeded 
in eliminating negative control amplification, the current set of primers were generated with a 
fluorescent probe to improve specificity (Table 2.2). Testing for primer concentration involved 
multiple trials run simultaneously, with 1 µL of primers and probe providing the most optimized 
results. The average annealing temperature for the primers and probe was calculated to 58°C, and 
proved to be the best temperature when testing of other temperatures yielded poorer results. 
However, negative control amplification persisted, leading to questions about how much 
contamination was present within the work space.  
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Table 3.1: All primer/probe quantities, concentrations, and annealing temperatures tested and their resultant R2, 
slope, and efficiency values. Those rows without R2, slope, and efficiency values were positive control tests. The 
rows marked in red were from a previous primer set that did not produce viable results. This primer set was run 
with SYBR Green (Agilent Technologies) rather than a probe and was run on the Quantitative PCR – DNA Binding 
Dye Including Standard Melt program. The rows marked in black were from the primer set and probe which 









R2 Slope Efficiency 
(%) 
2.5/5 N/A 60 N/A N/A N/A 
2.5/5 N/A 60 0.997 -3.142 108.1 
2.5/5 N/A 60 0.984 -2.828 125.7 
2/5 N/A 60 0.991 -2.840 125.0 
1.5/5 N/A 60 0.996 -2.787 128.5 
1/5 N/A 60 0.991 -2.670 136.9 
1/5 N/A 65 0.998 -3.137 108.3 
1/5 N/A 70 0.193 -0.818 1568 
0.5/5 N/A 65 0.997 -2.879 122.5 
1/5 N/A 62 0.996 -2.697 134.8 
1/5 N/A 65 0.998 -2.733 132.3 
1/5 N/A 62 0.996 -2.691 135.3 
1/5 N/A 62 0.992 -2.933 119.3 














R2 Slope Efficiency 
(%) 
0.5/5 N/A 65 0.993 -2.779 129.0 
0.5/5 N/A 55 N/A N/A N/A 
1/5 1/5 58 N/A N/A N/A 
1/5 0.4/5 58 N/A N/A N/A 
1/5 1/1 58 N/A N/A N/A 
1/5 0.4/1 58 N/A N/A N/A 
1/5 1/5 58 N/A N/A N/A 
1/5 1/5 60 N/A N/A N/A 
1/5 1/5 55 N/A N/A N/A 
1/5 1/5 58 N/A N/A N/A 
1/5 1/5 58 0.996 -2.993 115.8 
1/5 1/5 60 N/A N/A N/A 
1/5 1/5 58 0.992 -2.796 127.9 
1/5 1/5 62 N/A N/A N/A 
1/5 1/5 58 N/A N/A N/A 
1/5 1/5 58 N/A N/A N/A 
1/5 1/5 58 0.980 -3.180 106.3 




The final protocol which produced the most optimized results (Figure 3.1) for this primer 
set was established as 5 µL of water (Thermo Fisher Scientific), 10 µL of Brilliant III Ultra-Fast 
Probe Master Mix with Low ROX (Agilent Technologies), 1 µL of both the forward and reverse 
qnrB19 primer sets (Table 2.2) (IDT) (5µM), 1 µL of the qnrB19 probe (Table 2.2) (IDT) (5µM), 
and 2 µL of DNA template per reaction. The reactions were performed in duplicate by hand due 
to concerns about potential contamination originating from within the QIAgility (Qiagen). 
Reactions were prepared in total to 4.0 µL of template and 36.0 µL of Master Mix which was 
then hand-mixed and separated into 20 µL reactions for analysis. Reactions were performed in 
the AriaMx (Agilent Technologies) utilizing the Quantitative PCR – Fluorescence Probe 
program. The final PCR thermal profile began with 3 minutes at 95°C to initiate the reaction, 
followed by 40 repeating cycles of 5 seconds at 95°C followed by 10 seconds at 58°C with 





Figure 3.1: The qnrB19 optimized standard curve and amplification plots for the optimized protocol 
3.2 blaSHV-12 gene Protocol Optimization 
Multiple protocols were tested for the blaSHV-12 gene (Table 3.2), with primer 
concentration beginning at 2.5 µL and an annealing temperature of 60°C, which resulted in near 
ideal results upon the first run. However, negative control amplification proved to be an issue, 
and so further adjustment of primer concentrations and annealing temperatures was performed. 
However, none of these temperatures produced as clean of results as the initial ones tested, and 
none were successful in eliminating negative control amplification. As such, the same stricter 
cleaning protocols were implemented for the blaSHV-12 primers as were used for the qnrB19 
primers which also resulted in the successful generation of a standard curve by hand with the 
blaSHV-12 primer set.  
17 
 
Table 3.2: All primer quantities, concentrations, and annealing temperatures tested and their resultant R2, slope, 
and efficiency values. Those rows without R2, slope, and efficiency values were positive control tests. The row 
marked with a * are the values gathered from a single curve rather than a duplicate curve like all other trials. This 
was due to a pipetting error that occurred during the experiment and resulted in one complete and one incomplete 
standard curve. Only the results from the complete standard curve are recorded here. The highlighted row contains 







R2 Slope Efficiency (%) 
2.5/5 60 N/A N/A N/A 
2.5/5 60 0.997 -3.173 106.6 
2.5/5 65 0.996 -3.054 112.5 
2.5/5 60 N/A N/A N/A 
* 2.5/5 60 0.999 -3.569 90.6 
2.5/5 60 0.996 -3.328 99.8 
2.5/5 60 0.998 -3.266 102.4 





The final protocol which produced the most optimized results (Figure 3.2) for this primer 
set was established as 3 µL of water (Thermo Fisher Scientific), 10 µL of Brilliant III Ultra-Fast 
SYBR Green QPCR Master Mix with Low ROX (Agilent Technologies), 2.5 µL of the forward 
and reverse blaSHV-12 primers (5µM) (IDT), and 2 µL of DNA template per reaction. The 
reactions were performed in duplicate by hand due to concerns about potential contamination 
originating from within the QIAgility (Qiagen). Reactions were prepared to a total of 4.0 µL of 
template and 36.0 µL of Master Mix which was then hand-mixed and separated into 20 µL 
reactions for analysis. Reactions were performed in the AriaMx (Agilent Technologies) utilizing 
the Quantitative PCR – DNA Binding Dye Including Standard Melt program. The final PCR 
thermal profile began with 3 minutes at 95°C to initiate the reaction, followed by 40 repeating 
cycles of 5 seconds at 95°C followed by 10 seconds at 60°C with measurements taken following 





Figure 3.2: The blaSHV-12 primers optimized standard curve, amplification plots, and melt curve 
3.3 invA gene Protocol Optimization 
In testing of the invA gene, no standard curve was successfully generated with the primer 
and probe sets using the conditions previously published.[x] However, upon testing of the qPCR 
product through the use of a gel electrophoresis, product was detected in the positive control 
samples, with no product detected in the negative control samples (Figure 3.3). 
A separate test was run using a generalized fluorescent material rather than a fluorescent 




Figure 3.3: Gel electrophoresis of the invA gene positive control test, well 1 is the DNA ladder used for control, 
wells 2 and 4 are replicate PCR products containing the positive control (DNA from S. Senftenberg) and wells 3 and 





Figure 3.4: Positive test control amplification of two invA positive samples (ATCC 700720, a40heb1.1) utilizing a 
general fluorescent material rather than the fluorescent probe 
3.4 Discussion 
The standard curves generated for qnrB19 and blaSHV-12 both display results within 
acceptable ranges for further data analysis. Therefore, these results are applicable to sample 
testing and will provide acceptable standards against which to compare samples, allowing for 
gene quantification within samples. 
As no standard curve has yet been successfully generated for invA, this protocol cannot 
yet be utilized in sample testing. Possible options for further optimization are discussed in 
section 4.2. 
The primary issue which occurred over the course of both the qnrB19 and blaSHV-12 
protocol optimization process was negative control amplification. Over the course of both trials, 
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primer annealing temperatures were adjusted to see if doing so could either eliminate the 
negative control amplification entirely or push it to a point where it could be cut off from the 
final results. The standard cycle count for the qPCR programs used was 40, but if the standards 
could be fully amplified (brought to a plateau) before then, then the remaining cycles would be 
extraneous data and could be removed. If negative control amplification could be pushed to this 
region then it would become negligible, but this was not achieved. This showed some promise, 
with the negative control amplifying later in both trials, but also had negative effects on the R2, 
slope, and efficiency values of the generated standard curves, pushing the values beyond the 
acceptable ranges. The accepted range values for these are -3.58 to -3.10, 90% to 110%, and 
>0.99 for slope, efficiency, and R2, respectively.[15] The individual dilutions of the standard curve 
also changed with the temperature adjustments, with standards amplifying later or earlier 
depending on the direction of adjustment, but never separating the lower standards from the 
negative control to a point where the negative control could be cut off. 
The R2 value indicates how well the data points fit to the linear regression generated by 
the software based off of the data set, indicating how uniform the dilutions were in the reaction. 
The ideal value is 1, indicating a perfect fit and complete uniformity across the dilutions. The 
slope is the slope of the linear regression calculated from the data set, with the ideal slope being -
3.3, but values within the accepted range being used for publication. The efficiency indicates 
how much of the reaction amplified in early amplification cycles continued to amplify in 
subsequent cycles, with the ideal being 100% indicating that all the reaction continued.[15] 
The eventual solution to eliminating amplification of the negative control was a stricter 
cleaning protocol, with heavy decontamination of both work surfaces and tools used during the 
experiments. These surfaces were decontaminated with the use of DNA Away (Thermo Fisher 
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Scientific) and 70% ethanol (100% ethanol from Sigma-Aldrich; St. Louis, MO; combined with 
deionized water). The surface would be thoroughly coated with DNA Away (Thermo Fisher 
Scientific), left to sit for 10-15 seconds, and then wiped down. Subsequently, the surface would 
be sprayed down with ethanol (Sigma-Aldrich) and wiped immediately after. The DNA Away 
(Thermo Fisher Scientific) would eliminate any amplicons which may contaminate the negative 
control and the ethanol (Sigma-Aldrich) would remove the DNA Away (Thermo Fisher 
Scientific) to prevent degradation of the experiment. Materials used in the experiment were also 
replaced before the final protocols were created, both to reduce the risk of contamination and 
ensure that all materials utilized were fresh and would remove any error brought on by their 
degradation over time. While this protocol helped to reduce amplification within the QIAgility 
(Qiagen), some inconsistency still remained, leading to concerns about aerosols or amplicons 
present in parts of the machine not cleanable during normal operation. This led to the production 
of a standard curve by hand using the same cleaning protocol in order to reduce the chance of 
contamination. These modifications resulted in successful results for generating standard curves 
for both qnrB19 and blaSHV-12 that were free of negative control amplification and had R2, slope, 
and efficiency values within the acceptable ranges for publication. 
The final protocols were performed by hand as issues concerning contamination and 
pipetting error within the QIAgility (Qiagen) were raised. In previous trials the machine 
generated differing volumes of product despite being programmed to dispense the same amount 
in each well. The final trials were performed by hand to remove this issue, as although the 
QIAgility (Qiagen) offers greater consistency in results, the need to remove the pipetting errors 
outweighed any human error performing the experiment by hand may generate. 
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The concern of contamination was also raised. Despite thorough decontamination and 
careful handling of products, some negative controls generated within the QIAgility (Qiagen) 
still displayed amplification, while those generated by hand did not. This indicated that either 
aerosols were being generated during the reaction which contaminated results or that some 
amplicons were present in areas that were unable to be reached for cleaning during routine 
operation. As such, performing the experiments by hand also assisted to eradicate this issue. 
The invA gene protocol was not successfully optimized. The primary issue with this gene 
was the lack of detection. Upon completion of the experiment, it appeared that no standard curve 
had been generated, however, upon running the PCR products through a gel electrophoresis, it 
became apparent that product had been produced in the positive controls and no product had 
been produced in the negative controls. This indicated that the issue lay not within the actual 
reaction, but the detection of the reaction’s occurrence. This was further reinforced by the 
presence of product when the trial was later run using a general fluorescent material and 
removing the probe from the reaction, indicating that the probe was the likely issue. As the 
protocol has not been fully optimized yet it cannot be said for sure that this is the problem, but 






Despite initial difficulties with negative control amplification, sufficiently intense 
cleaning of materials and workspace to remove possible contaminants has proved successful in 
eliminating negative control amplification. In addition, replacing the water for every reaction has 
also ensured that as many possible sources of contamination are removed as is reasonably 
feasible. 
The successful elimination of negative control amplification has resulted in standard 
curve generation with acceptable slope, efficiency, and R2 values for the genes qnrB19 and 
blaSHV-12 which can later be used for sample testing. Protocols have not yet been optimized for 
standard curve generation of the invA gene; however, preliminary results have shown successful 
amplification of positive controls and no amplification of negative controls as is desired. 
4.2 Future Plans 
Future plans include acquisition of a new probe for the invA primer set. It is possible that 
the age of the utilized probes, having been ordered in 2019, may be a contributing factor in the 
failure to detect amplification. If the present fluorescent issue can be explained via the age and 
potential degradation of the current materials then use of a freshly created probe should allow for 
detection of standard curve amplification and resolve the current issue. If the new probe fails to 
fluoresce then a new probe entirely may have to be designed or another alternate route may be 
considered. If the curve fluoresces but is not within acceptable ranges for data analysis the 
protocol may have to be further adjusted. 
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If the fresh invA probe allows for the generation of an acceptable standard curve then 
sample testing for this gene will begin immediately. 
New standard curves for qnrB19 and blaSHV-12 will also be generated to ensure that all 
materials in use are fresh. Assuming the standard curves remain within the previously described 
acceptable ranges, sample testing for these genes will begin immediately. Generation of new 
standard curves for qnrB19 and blaSHV-12 will also confirm the repeatability of the optimized 
protocol. 
In conclusion, the protocols for the qnrB19 gene and blaSHV-12 gene were successfully 
optimized with new primer generation, annealing temperature adjustment, and stricter cleaning 
protocols. The protocol for the invA gene was not optimized, but future plans, such as ordering 
fresh probe, include possible routes for fixing the detection issues. Fecal sample testing will 
begin for the qnrB19 and blaSHV-12 genes as those protocols are already optimized, and sample 
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